Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Recruiting · NCT06529406 · Registry updated 2025-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod | Relapsing Multiple Sclerosis | Recruiting | Phase 4 | 2025-09-18 | NCT06529406 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Colorado, Denver | 475 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Las Vegas | United States | 3 |
| Cleveland Clinic | Cleveland | United States | 558 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |